The challenges of using Escherichia coli as a host in recombinant insulin production

Diabetes mellitus is a metabolic disease characterised by elevation of blood glucose level which leads to serious damage to the blood vessels, eyes, heart, kidney, and nerves affecting about 830 million people worldwide. The most common diabetes is type 2 which usually happened in adults when the b...

Full description

Saved in:
Bibliographic Details
Main Author: Muhammad Taher
Format: Article
Language:English
Published: IIUM Press, International Islamic University Malaysia 2025-01-01
Series:Journal of Pharmacy
Online Access:https://journals.iium.edu.my/ktn/index.php/jp/article/view/380
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576602282655744
author Muhammad Taher
author_facet Muhammad Taher
author_sort Muhammad Taher
collection DOAJ
description Diabetes mellitus is a metabolic disease characterised by elevation of blood glucose level which leads to serious damage to the blood vessels, eyes, heart, kidney, and nerves affecting about 830 million people worldwide. The most common diabetes is type 2 which usually happened in adults when the body becomes resistant to insulin, or the body does not produce enough insulin. Type 1 diabetes mellitus is dependent on insulin which required accessible and affordable insulin (Diabetes, 2025). In Malaysia, the prevalence of diabetes mellitus (DM), depends on factors such as gender, age, and ethnicity, with women, the elderly, and the Indian community having the highest prevalence of DM. In the 103,063 participants that made up the study's sample, the combined prevalence of diabetes by gender in the population-based studies was 13.80% for men and 14.54% for women, while the combined prevalence of prediabetes was 11.40% for women and 10.98% for men (Akhtar et al., 2022). For age, from this study, it can be observed that the prevalence of diabetes showed a notable upward trend as people aged, rising from 3.16% in the 20–29 age group to 13.71% in the 30-45 age group, 25.66% in the 46–59 age group, and 33.45% in the 60 and older age group (Akhtar et al., 2022). Ethnicity and races can also affect the prevalence of DM. The subpopulation of Indian had the greatest prevalence of diabetes which is 25.10%, among all ethnic groups, followed by Malay with 15.25%, Chinese with 12.87%, Bumiputera with 8.62%, and others with 6.91%. The prevalence demands oral hypoglycaemic agents (OHAs) market size in Malaysia at USD282.22 million in 2025 with a CAGR of greater than 3% during forecast period (2025-2030). The drugs are mainly fall under the following segment: biguanides, alpha-glucosidase inhibitors, dopamine-d2 receptor agonists, sodium-glucose cotransport-2 (SGLT-2) inhibitor, dipeptidyl peptidase-4 (DPP-4) inhibitors, sulfonylureas, and meglitinides (Malaysia Oral Anti-Diabetic Drug Market Size | Mordor Intelligence, 2025).
format Article
id doaj-art-28073527d3914d0ca0456d906500e301
institution Kabale University
issn 2773-5664
language English
publishDate 2025-01-01
publisher IIUM Press, International Islamic University Malaysia
record_format Article
series Journal of Pharmacy
spelling doaj-art-28073527d3914d0ca0456d906500e3012025-01-31T01:08:54ZengIIUM Press, International Islamic University MalaysiaJournal of Pharmacy2773-56642025-01-015110.31436/jop.v5i1.380The challenges of using Escherichia coli as a host in recombinant insulin production Muhammad Taher0IIUM Diabetes mellitus is a metabolic disease characterised by elevation of blood glucose level which leads to serious damage to the blood vessels, eyes, heart, kidney, and nerves affecting about 830 million people worldwide. The most common diabetes is type 2 which usually happened in adults when the body becomes resistant to insulin, or the body does not produce enough insulin. Type 1 diabetes mellitus is dependent on insulin which required accessible and affordable insulin (Diabetes, 2025). In Malaysia, the prevalence of diabetes mellitus (DM), depends on factors such as gender, age, and ethnicity, with women, the elderly, and the Indian community having the highest prevalence of DM. In the 103,063 participants that made up the study's sample, the combined prevalence of diabetes by gender in the population-based studies was 13.80% for men and 14.54% for women, while the combined prevalence of prediabetes was 11.40% for women and 10.98% for men (Akhtar et al., 2022). For age, from this study, it can be observed that the prevalence of diabetes showed a notable upward trend as people aged, rising from 3.16% in the 20–29 age group to 13.71% in the 30-45 age group, 25.66% in the 46–59 age group, and 33.45% in the 60 and older age group (Akhtar et al., 2022). Ethnicity and races can also affect the prevalence of DM. The subpopulation of Indian had the greatest prevalence of diabetes which is 25.10%, among all ethnic groups, followed by Malay with 15.25%, Chinese with 12.87%, Bumiputera with 8.62%, and others with 6.91%. The prevalence demands oral hypoglycaemic agents (OHAs) market size in Malaysia at USD282.22 million in 2025 with a CAGR of greater than 3% during forecast period (2025-2030). The drugs are mainly fall under the following segment: biguanides, alpha-glucosidase inhibitors, dopamine-d2 receptor agonists, sodium-glucose cotransport-2 (SGLT-2) inhibitor, dipeptidyl peptidase-4 (DPP-4) inhibitors, sulfonylureas, and meglitinides (Malaysia Oral Anti-Diabetic Drug Market Size | Mordor Intelligence, 2025). https://journals.iium.edu.my/ktn/index.php/jp/article/view/380
spellingShingle Muhammad Taher
The challenges of using Escherichia coli as a host in recombinant insulin production
Journal of Pharmacy
title The challenges of using Escherichia coli as a host in recombinant insulin production
title_full The challenges of using Escherichia coli as a host in recombinant insulin production
title_fullStr The challenges of using Escherichia coli as a host in recombinant insulin production
title_full_unstemmed The challenges of using Escherichia coli as a host in recombinant insulin production
title_short The challenges of using Escherichia coli as a host in recombinant insulin production
title_sort challenges of using escherichia coli as a host in recombinant insulin production
url https://journals.iium.edu.my/ktn/index.php/jp/article/view/380
work_keys_str_mv AT muhammadtaher thechallengesofusingescherichiacoliasahostinrecombinantinsulinproduction
AT muhammadtaher challengesofusingescherichiacoliasahostinrecombinantinsulinproduction